SCHEMBL29978291

SCHEMBL29978291

Cc1cccc(C2CCN(c3ccccc3NS(=O)(=O)c3ccc(S(=O)(=O)N(C)C)cc3)CC2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCOLN2 Q8IZK6 2/20 0.48
MCOLN3 Q8TDD5 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
PKM P14618 1/20 0.46
ALDH1A1 P00352 4/20 0.45
LMNA P02545 3/20 0.45
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 2/20 0.44
MAPT P10636 1/20 0.44
XBP1 P17861 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MCOLN1 Q9GZU1 1/20 0.44
GAA P10253 4/20 0.42
GFER P55789 1/20 0.41
CCR5 P51681 1/20 0.41
USP5 P45974 1/20 0.41
POLB P06746 1/20 0.41
BRPF1 P55201 1/20 0.41
TSHR P16473 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23057037 1.00 MCOLN2 (0.48) MCOLN2MCOLN3L3MBTL1PKMALDH1A1
SCHEMBL23057335 0.92 MCOLN3 (0.47) MCOLN2MCOLN3L3MBTL1PKMALDH1A1
SCHEMBL23044597 0.91 MCOLN3 (0.51) MCOLN2MCOLN3L3MBTL1PKMALDH1A1
SCHEMBL23057094 0.90 L3MBTL1 (0.47) MCOLN2MCOLN3L3MBTL1PKMALDH1A1
SCHEMBL29979302 0.90 L3MBTL1 (0.47) MCOLN2MCOLN3L3MBTL1PKMALDH1A1
SCHEMBL23355039 0.85 MCOLN2 (0.47) MCOLN2MCOLN3L3MBTL1PKMALDH1A1
SCHEMBL23057145 0.83 L3MBTL1 (0.53) MCOLN2MCOLN3L3MBTL1PKMALDH1A1
SCHEMBL23379508 0.83 MCOLN3 (0.56) MCOLN2MCOLN3L3MBTL1PKMALDH1A1
SCHEMBL23057166 0.82 MCOLN3 (0.52) MCOLN2MCOLN3L3MBTL1PKMALDH1A1
SCHEMBL23057180 0.80 MCOLN3 (0.68) MCOLN2MCOLN3L3MBTL1PKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 MCOLN2 2/4885MCOLN3 3/4885L3MBTL1 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.